Oncology
Study maps self-reinforcing SRSF1–AURKA–MYC circuit in pancreatic cancer cells
Raportoinut AI AI:n luoma kuva Faktatarkistettu
Researchers at Cold Spring Harbor Laboratory report they have identified a three-part molecular circuit involving SRSF1, Aurora kinase A (AURKA) and MYC that helps drive aggressive pancreatic ductal adenocarcinoma. In laboratory models, a splice-switching antisense oligonucleotide designed to alter AURKA splicing disrupted the circuit, reducing tumor-cell viability and triggering programmed cell death.
One month after the nationwide oncology sanitary alert took effect, Health Minister May Chomali led the signing of a decree transferring $154 billion from the Ministry of Hacienda to the Ministry of Health (Minsal). The funds will exclusively support the Oncology Alert Plan, enhancing public health services' capacity to resolve oncology waiting lists affecting thousands of patients.
Raportoinut AI
Governor Alfonso Durazo Montaño announced the operation of a high-tech linear accelerator at Sonora's State Oncology Center, with an 80 million peso investment, starting this Thursday, April 16. The equipment will double radiotherapy sessions from 11,000 to 22,000 annually and cut wait times from six months to one month, free through IMSS-Bienestar. Four priority hospital infrastructure projects were also unveiled.
Oncologist Paulo Hoff warned that excessive sun exposure is the most common cause of cancer, particularly non-melanoma skin cancer. In a course on CasaFolha, he emphasizes the importance of prevention and early diagnosis to boost cure rates. Hoff recommends avoiding the sun between 10am and 2pm and using sunscreen.
Raportoinut AI Faktatarkistettu
Researchers at Weill Cornell Medicine report that tumors exploit a CD47–thrombospondin-1 signal to push T cells into exhaustion, and that interrupting the interaction restores T cell activity and slows tumor growth in mouse models. The study was published on November 17, 2025, in Nature Immunology.
Researchers at Spain's National Cancer Research Centre (CNIO) have developed a comprehensive catalog of mutational 'scars' in DNA caused by cancer. This breakthrough, published in Nature, could help bypass resistances to treatments like PARP inhibitors. The study analyzes thousands of tumor samples to identify key genetic patterns.
Raportoinut AI Faktatarkistettu
Vaccine therapy for malignant glioma is advancing, with calls for expedited approvals to treat this aggressive brain cancer. The approach has potential to save lives and is part of efforts for rare disease treatments. Early results indicate effectiveness without traditional chemo or radiation.
Roche shares decline after giredestrant trial fails endpoint
19. helmikuuta 2026 03.55Stf approves agreement for funding oncology treatments in Sus
18. helmikuuta 2026 04.47Egypt and Canada deepen healthcare cooperation focusing on digital health and oncology
13. helmikuuta 2026 17.37Cuba battles cancer amid shortages
3. helmikuuta 2026 10.20Egypt's health minister discusses new oncology centres with Siemens Healthineers
2. marraskuuta 2025 03.05Clínica Medilaser leads blood cancer diagnosis and treatment
30. lokakuuta 2025 14.26Eastern Cape chemotherapy shortages risk pediatric patients
22. lokakuuta 2025 07.57Drug combination slows progression of aggressive prostate cancer
20. lokakuuta 2025 00.43Study confirms rise in cancer cases among adults under 50
20. lokakuuta 2025 00.10Drug combo cuts prostate cancer death risk by over 40 percent